Cargando…

Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019

BACKGROUND: Sites of entry for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly expressed in nasal epithelial cells; however, little is known about the impact of intranasal corticosteroids (INCS) on coronavirus disease 2019 (COVID-19)-related outcomes. OBJECTIVE: To determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strauss, Ronald, Jawhari, Nesreen, Attaway, Amy H., Hu, Bo, Jehi, Lara, Milinovich, Alex, Ortega, Victor E., Zein, Joe G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381621/ https://www.ncbi.nlm.nih.gov/pubmed/34438103 http://dx.doi.org/10.1016/j.jaip.2021.08.007

Ejemplares similares

Eosinophilia is Associated with Improved COVID-19 Outcomes in Patients Treated with Inhaled Corticosteroids
por: Strauss, Ronald, et al.
Publicado: (2022)

Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients
por: Zein, Joe G., et al.
Publicado: (2022)

Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022)

Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results From 11,672 Patients
por: Jehi, Lara, et al.
Publicado: (2020)

An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness
por: Kattan, Michael W., et al.
Publicado: (2020)

Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry
por: Sen, Payal, et al.
Publicado: (2021)

Using intranasal corticosteroids
por: Fowler, James, et al.
Publicado: (2021)

The relationship of asthma severity to COVID-19 outcomes
por: Zein, Joe G., et al.
Publicado: (2022)

SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry
por: Attaway, Amy A, et al.
Publicado: (2020)

The subtle nuances of intranasal corticosteroids
por: Fowler, James, et al.
Publicado: (2021)

The Treatment of Vasomotor Rhinitis With Intranasal Corticosteroids
por: Meltzer, Eli O
Publicado: (2009)

Safety of intranasal corticosteroids in acute rhinosinusitis
por: Demoly, Pascal
Publicado: (2008)

Asthma, biologics, corticosteroids, and coronavirus disease 2019
por: Akenroye, Ayobami T., et al.
Publicado: (2020)

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19
por: Jehi, Lara, et al.
Publicado: (2020)

Inadequate quality of administration of intranasal corticosteroid sprays
por: Rollema, Corine, et al.
Publicado: (2019)

Medical adherence to intranasal corticosteroids in adult patients()
por: Ocak, Emre, et al.
Publicado: (2016)

Corticosteroids: A Controversial Therapy for Coronavirus Disease 2019
por: She, Jun, et al.
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter
por: Maeda, Yohei, et al.
Publicado: (2022)

Evaluation of the techniques and steps of intranasal corticosteroid sprays administration
por: Rattanawong, Supachet, et al.
Publicado: (2022)

Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022)

Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?
por: Leong, Yuen Chin, et al.
Publicado: (2020)

Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index
por: Daley-Yates, Peter T, et al.
Publicado: (2021)

COVID-19 Home Monitoring After Diagnosis and Health Care Utilization in an Integrated Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2021)

Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
por: Lim, William, et al.
Publicado: (2021)

Corticosteroids Utilization in the Management of Critically Ill Coronavirus Disease-2019 Pneumonia
por: Yang, Cheng, et al.
Publicado: (2022)

Effects of early corticosteroid use in patients with severe coronavirus disease 2019
por: Hyun, Jong Hoon, et al.
Publicado: (2021)

Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
por: Bridgeman, Mary Barna
Publicado: (2017)

Multiple Joint Osteonecrosis in a Patient on Long-term Intranasal Corticosteroids
por: Yousef, Mohamed A., et al.
Publicado: (2020)

Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids
por: Martinez-Paredes, Jhon F., et al.
Publicado: (2022)

Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020)

Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis
por: Cano, Edison J., et al.
Publicado: (2021)

Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
por: Veronese, Nicola, et al.
Publicado: (2020)

Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
por: Waterhouse, Jasmin V., et al.
Publicado: (2020)

Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid
por: Takumida, Hiroshi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022)

Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022)

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
por: Misaki, Yumiko, et al.
Publicado: (2023)

Medication Adherence to Intranasal Corticosteroids in Allergic Rhinitis Patients with Comorbid Medical Conditions
por: Manjit Singh, Prempreet Kaur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tt4u5tpa6sktkuftcq44mdmbq5